We carried out a systematic review to summarize available data regarding prevalence of high-risk human papillomavirus (HR-HPV) among women living with HIV (WLHIV) in Latin America and the Caribbean (LAC). A literature search in PubMed and LILACS was conducted and supplemented with cross-referencing and grey literature. The primary outcome was prevalence of HR-HPV by age as a major determinant of HPV infection. Pooled prevalence and weighted averages were obtained. A random effects meta-analysis conducted for HPV- and HIV-associated factors. In total, 6157 women from 19 cross-sectional studies were included. Weighted prevalence of HR-HPV in WLHIV was 51.0% (95% CI 42.8–59.1, I2 = 97.4%) with a bimodal trend by age. No association between antiretroviral therapy and HR-HPV prevalence was observed, but low CD4 cell count was associated (PR 1.64, 95% CI 1.07–2.52). Although not significant, a higher HR-HPV prevalence was observed with Hybrid Capture 2 versus PCR. The high prevalence of HR-HPV among WLHIV in LAC underlines the need for improved cervical cancer prevention and early detection in this vulnerable population. Moreover, the high prevalence across age groups, and particularly in young women, deserves careful consideration for defining target populations of HPV-based screening and HPV immunization programs.
International Agency for Research on Cancer. Global cancer observatory: cancer today. Available from: https://gco.iarc.fr/ (2018, accessed 15 May 2020) [Internet].
2.
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva. World Health Organization 2020. Licence: CC BY-NC-SA 3.0 IGO
3.
AbrahamAGD’SouzaGJingY, et al.Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr2013; 62(4): 405–413.Available from: https://insights.ovid.com/crossref?an=00126334-201304010-00006. [Internet]. [cited 2019 Nov 26]
4.
MohammedDYShuklaPBabayantsY, et al.Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016. Int J Womens Health2018; 10: 83–87.
5.
RohnerEBütikoferLSchmidlinK, et al.Cervical cancer risk in women living with HIV across four continents: a multicohort study. Int J Cancer2020; 146(3): 601–609.
6.
StelzleDTanakaLFLeeKK, et al.Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021; 9(2): e161–e169.Available from: https://linkinghub.elsevier.com/retrieve/pii/S2214109X20304599 [Internet]. [cited 2021 Feb 26].
7.
UNAIDS. HIV estimates from 1990 to present. [Internet]. Available from: https://www.unaids.org/en/topic/data (2019, accessed 4 June 2020) [Internet].
8.
LiuGSharmaMTanN, et al.HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS2018; 32(6): 795–808.http://Insights.ovid.com/crossref?an=00002030-201803270-00013 Mar [cited 2019 Nov 27]. Available from:
9.
DenslowSARositchAFFirnhaberC, et al.Incidence and progression of cervical lesions in women with HIV: a systematic global review. Int J STD AIDS2014; 25(3): 163–177.
10.
WeldegebrealFWorkuT. Precancerous cervical lesion among HIV-positive women in Sub-Saharan Africa: a systematic review and meta-analysis. Cancer Control2019; 26: 1073274819845872.
11.
CliffordGMGonçalvesMAFranceschiS. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS2006; 20: 2337–2344.
12.
MurilloRAlmonteMPereiraA, et al.Cervical cancer screening programs in Latin America and the Caribbean. Vaccine2008; 26(Suppl 11): L37–L48.
13.
MurilloRHerreroRSierraMS, et al.Cervical cancer in central and South America: burden of disease and status of disease control. Cancer Epidemiol2016; 44(Suppl 1): S121–S130.
14.
Caicedo-MartínezMOrdoñez-ReyesCFernández-DeazaG, et al.Cervical cancer epidemiology, prevention and screening among women living with HIV in the Americas region: a systematic review protocol. Univ Med2020; 61(4): 80–87.
15.
MoherDLiberatiATetzlaffJ, et al.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med2009; 6(7): e1000097. DOI: 10.1371/journal.pmed.1000097.[cited 2020 Apr 8] Available from:
16.
DownesMJBrennanMLWilliamsHC, et al.Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open2016; 6(12): e011458. DOI: 10.1136/bmjopen-2016-011458[cited 2019 Nov 28]Available from:
17.
BoosCJDe VilliersNDyballD, et al.The relationship between military combat and cardiovascular risk: a systematic review and meta-analysis. Int J Vasc Med2019; 2019: 1–14. https://www.hindawi.com/journals/ijvm/2019/9849465/.[cited 2020 Nov 13] Available from:
18.
Scottish Intercollegiate Guidelines Network. Critical appraisal notes and checklists. Edinburg: Scottish Intercollegiate Guidelines Network. Available from: https://www.sign.ac.uk/checklists-and-notes (2018, accessed 28 May 2020) [Internet].
19.
The R Foundation for Statistical Computing. Platform: x86_64-pc-linux-gnu (64-bit). New Jersey: Bunny-Wunnies Freak Out, 2020.
20.
de AndradeACLuzPMVelasqueL, et al.Factors associated with colposcopy-histopathology confirmed cervical intraepithelial neoplasia among HIV-infected women from Rio De Janeiro, Brazil. PLoS One2011; 6(3): e18297.
21.
SilvaLdMirandaABatalhaR, et al.High-risk human papillomavirus and cervical lesions among women living with HIV/AIDS in Brazilian Amazon, Brazil. Braz J Infect Dis2015; 19(6): 557–562.
22.
TexeiraNCPAraujoACLCorreaCM, et al.Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women. 2012;16(2):164–169.
23.
LeviJEFinkMCCantoCL, et al.Human papillomavirus prevalence, viral load and cervical intraepithelial Neoplasia in HIV-infected women. Braz J Infect Dis2002; 6: 129–135.
24.
MartinsAELucena-SilvaNGarciaRG, et al.Prevalence of human papillomavirus infection, distribution of viral types and risk factors in cervical samples from human immunodeficiency virus-positive women attending three human immunodeficiency virus-acquired immune deficiency syndrome reference centres in northeastern Brazil. Mem Inst Oswaldo Cruz2014; 109(6): 738–47. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762014000600738&lng=en&tlng=en;[cited 2019 Dec 9] Available from:
25.
VolkowPRubíSLizanoM, et al.High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus. Gynecol Oncol2001; 82(1): 27–31, https://linkinghub.elsevier.com/retrieve/pii/S0090825801962444;[cited 2019 Dec 9].
26.
CarvalhoAZ. Estudo socioepidemiológico, clínico e de genotipagem do Papilomavírus Humano em mulheres com HIV/AIDS. Fortaleza: Universidad Federal de Ceará, 2016.
27.
GrinsztejnBBastosFIVelosoVG, et al.Assessing sexually transmitted infections in a cohort of women living with HIV/AIDS, in Rio de Janeiro, Brazil. Int J STD AIDS2006; 17(7): 473–478.
GrinsztejnBVelosoVGLeviJE, et al.Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women. Int J Infect Dis2009; 13(1): 72–80.
30.
EntiauspeLGSeixasFKNunesEM, et al.Uncommon non-oncogenic HPV genotypes, TP53 and MDM2 genes polymorphisms in HIV-infected women in Southern Brazil. Braz J Infect Dis2014; 18(6): 643–650. https://linkinghub.elsevier.com/retrieve/pii/S1413867014001706 [cited 2019 Dec 9] Available from:
31.
GonçalvesMAMassadEBurattiniMN, et al.Relationship between human papillomavirus (HPV) genotyping and genital neoplasia in HIV-positive patients of Santos City, São Paulo, Brazil. Int J STD AIDS1999; 10(12): 803–807. DOI: 10.1258/0956462991913583[cited 2019 Dec 9] Available from:
32.
LeviJEKleterBQuintWG, et al.High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol2002; 40(9): 3341–3345. DOI: 10.1128/JCM.40.9.3341-3345.2002;[cited 2019 Dec 9] Available from:
33.
OrtizAPTamayoVScorsoneA, et al.Prevalence and correlates of cervical HPV infection in a clinic-based sample of HIV-positive Hispanic women. Papillomavirus Res2017; 4: 39–44. https://linkinghub.elsevier.com/retrieve/pii/S240585211730006X.[cited 2019 Dec 9]. Available from:
34.
CastilhoJLLeviJELuzPM, et al.A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil. BMC Cancer2015; 15(1): 478. DOI: 10.1186/s12885-015-1486-4;Available from:
35.
DamesDNBlackmanEButlerR, et al.High-risk cervical human papillomavirus infections among human immunodeficiency virus-positive women in the Bahamas. PLoS One2014; 9(1): e85429. DOI: 10.1371/journal.pone.0085429.[cited 2019 Dec 9] Available from:
36.
MirandaAESilveiraMFTravassosAG, et al.High-risk papillomavirus infection among women living with human Immunodeficiency virus: Brazilian multicentric study. J Med Virol2017; 89(12): 2217–2223. DOI: 10.1002/jmv.24906. Available from:
37.
CorrêaCMTeixeiraNCPde AraújoACL, et al.Prevalence and multiplicity of HPV in HIV women in Minas Gerais, Brazil. Rev Assoc Med Bras (1992)2011; 57(4): 425–30.
38.
CamargoMDel Río-OspinaLSoto-De LeónSC, et al.Association of HIV status with infection by multiple HPV types. Trop Med Int Health2018; 23(11): 1259–1268.
CliffordGMTullySFranceschiS. Carcinogenicity of human papillomavirus (HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer. Clin Infect Dis2017; 64(9): 1228–1235. DOI: 10.1093/cid/cix135[cited 2019 Dec 9] Available from:
41.
TakuOBusingeCBMdakaML, et al.Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa. Int J Infect Dis2020; 95: 176–182. https://linkinghub.elsevier.com/retrieve/pii/S1201971220301090[cited 2021 Jan 12] Available from:
42.
DartellMRaschVMunkC, et al.Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania. Sex Transm Dis2013; 40(9): 737–43. http://journals.lww.com/00007435-201309000-00012 [cited 2021 Jan 12]. Available from:
43.
MbulawaZZCoetzeeDWilliamsonAL. Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status. BMC Infect Dis2015; 15(1): 459. DOI: 10.1186/s12879-015-1181-8
44.
KellyHANgouJChikandiwaA, et al.Associations of human papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa. PLoS One2017; 12; e0174117. DOI: 10.1371/journal.pone.0174117[Internet]Mar 23 [cited 2020 Jul 23]3Available from:
45.
KellyHWeissHABenaventeY, et al.Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV2017; 5: e45–e58.
46.
MuñozNMéndezFPossoH, et al.Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis2004; 190(12): 2077–2087.
47.
RamaCHRoteli-MartinsCMDerchainSFM, et al.Prevalência do HPV em mulheres rastreadas para o câncer cervical. Rev Saúde Pública2008; 42(1): 123–130.
48.
CastlePESchiffmanMHerreroR, et al.A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis2005; 191(11): 1808–1816.
49.
World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organization; 2013, p. 40.
50.
KoliopoulosGNyagaVNSantessoN, et al.Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 8(8):CD008587. DOI: 10.1002/14651858.CD008587.pub2.
51.
MurilloROrdóñez-ReyesC. Human papillomavirus (HPV) vaccination: from clinical studies to immunization programs. Int J Gynecol Cancer2019; 29(8): 1317–1326. DOI: 10.1136/ijgc-2019-000582[Internet][cited 2020 Jun 12] Available from:
52.
BruniLAlberoGSerranoB, et al.Human papillomavirus and related diseases in Americas. Barcelona: Institute Catalan de Oncology/International Agency for Research on Cancer, 2019.
PeytonCLSchiffmanMLörinczAT, et al.Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol1999; 37(2): 478. DOI: 10.1128/JCM.36.11.3248-3254.1998.Erratum in
Pan American Health Organization. Plan of action for the prevention and control of HIV and sexually transmitted infections 2016-2021. Washington DC: Pan American Health Organization, 2016.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
